Palm: Analysts' Upgrades, Downgrades

Stock quotes in this article: PALM , BHI , CVA , GOOG , HMA , GS , ALL  

Adam Feuerstein will be the featured guest on TSC Live at noon EDT Tuesday, Sept. 22. Send him your questions by: Emailing us at tsclive@thestreet.com; posting them on our Facebook page, facebook.com/thestreet; Tweeting us @thestreet_news with #tsclive; or posting them on the live show page in the comments section. Bookmark the TSC Live page now.

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Allstate (ALL Quote) upgraded at Argus from Hold to Buy. $36 price target. Company is taking steps to lower expenses and earnings should grow in 2010.

Baker Hughes (BHI Quote) upgraded at Morgan Stanley from Equal-weight to Overweight. $90 price target. Visibility is improving for the company's international growth strategy.

Boyd Gaming (BYD Quote) upgraded at Argus from Sell to Buy. $17 price target. Delay at Echelon Place will prove to be a wise choice.

Covanta (CVA Quote) downgraded at Barclays from Overweight to Equal-weight. $20 price target. Company business has less leverage in an economic recovery.

Coventry Health (CVH Quote) downgraded at Buy to Hold at Citigroup. Valuation call, as the stock has outperformed the market and its peers year-to-date.

Chevron (CVX Quote) upgraded at Credit Suisse to Outperform. $80 price target. Company is the best positioned integrated oil name in the current cycle.

E*Trade Financial (ETEF Quote) upgraded at Goldman from Neutral to Buy. Company is taking advantage of credit trends and benefiting from improved trading volume.

Genzyme (GENZ Quote) downgraded at Deutsche Bank. Rating lowered to Hold from Buy. Maintains $61 price target and 2009 EPS estimates of $2.41.

KB Home (KBH Quote) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $25.50 from $10.00. Maintains 2009 EPS estimates of -$2.44.

Lincoln National (LNC Quote) rated new Outperform at FBR. $35 price target. Company is well capitalized and is leveraged to an improving economy.

Allscripts-Misys (MDRX Quote) upgraded at Piper from Neutral to Overweight. $22.50 price target. Company just signed its largest ever contract.

  • Loading Comments...
  •  
< Previous
1 2 3 4 5

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.05
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services